R. Caprilli

10.5k total citations
132 papers, 5.4k citations indexed

About

R. Caprilli is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, R. Caprilli has authored 132 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Genetics, 66 papers in Epidemiology and 49 papers in Surgery. Recurrent topics in R. Caprilli's work include Inflammatory Bowel Disease (80 papers), Microscopic Colitis (56 papers) and Helicobacter pylori-related gastroenterology studies (21 papers). R. Caprilli is often cited by papers focused on Inflammatory Bowel Disease (80 papers), Microscopic Colitis (56 papers) and Helicobacter pylori-related gastroenterology studies (21 papers). R. Caprilli collaborates with scholars based in Italy, United States and United Kingdom. R. Caprilli's co-authors include Angelo Viscido, Giovanni Latella, Piero Vernia, Giuseppe Frieri, Adriana Marcheggiano, Giovanni Corrao, Francesca Maccioni, Claudio Papi, Antonella Vetuschi and Eugenio Gaudio and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

R. Caprilli

131 papers receiving 5.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R. Caprilli 2.8k 2.2k 2.1k 830 680 132 5.4k
Christian Maaser 2.7k 1.0× 1.8k 0.8× 2.1k 1.0× 665 0.8× 443 0.7× 117 5.6k
Livia Biancone 4.0k 1.4× 1.9k 0.8× 2.8k 1.3× 1.1k 1.3× 664 1.0× 199 6.9k
Íngrid Ordás 4.6k 1.6× 2.2k 1.0× 3.2k 1.5× 802 1.0× 590 0.9× 86 6.3k
Rami Eliakim 2.4k 0.9× 1.4k 0.6× 1.7k 0.8× 500 0.6× 605 0.9× 83 3.9k
Giovanni Latella 1.8k 0.6× 1.3k 0.6× 1.3k 0.6× 969 1.2× 598 0.9× 134 4.3k
Henry D. Janowitz 3.4k 1.2× 3.2k 1.4× 3.3k 1.6× 600 0.7× 774 1.1× 218 7.3k
Miquel Sans 3.2k 1.1× 1.8k 0.8× 2.2k 1.1× 1.1k 1.3× 397 0.6× 109 6.0k
Pieter Stokkers 4.0k 1.4× 2.2k 1.0× 2.5k 1.2× 768 0.9× 574 0.8× 133 6.4k
Stuart Bloom 2.4k 0.9× 1.3k 0.6× 1.6k 0.8× 583 0.7× 281 0.4× 114 4.4k
H. J. F. Hodgson 1.3k 0.5× 1.7k 0.8× 1.5k 0.7× 533 0.6× 251 0.4× 125 4.4k

Countries citing papers authored by R. Caprilli

Since Specialization
Citations

This map shows the geographic impact of R. Caprilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Caprilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Caprilli more than expected).

Fields of papers citing papers by R. Caprilli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Caprilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Caprilli. The network helps show where R. Caprilli may publish in the future.

Co-authorship network of co-authors of R. Caprilli

This figure shows the co-authorship network connecting the top 25 collaborators of R. Caprilli. A scholar is included among the top collaborators of R. Caprilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Caprilli. R. Caprilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caprilli, R., Monica Cesarini, Erika Angelucci, & Giuseppe Frieri. (2009). The long journey of salicylates in ulcerative colitis: The past and the future. Journal of Crohn s and Colitis. 3(3). 149–156. 31 indexed citations
2.
Latella, Giovanni, Antonella Vetuschi, Roberta Sferra, et al.. (2009). Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid–induced colorectal fibrosis. European Journal of Clinical Investigation. 39(2). 145–156. 50 indexed citations
3.
Papi, Claudio, Annalisa Aratari, Valentina Tornatore, et al.. (2009). Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine. Journal of Crohn s and Colitis. 3(2). 109–114. 7 indexed citations
4.
Caprilli, R.. (2008). Why does Crohn's disease usually occur in terminal ileum?. Journal of Crohn s and Colitis. 2(4). 352–356. 25 indexed citations
5.
Caprilli, R., et al.. (2008). Historical evolution of the management of severe ulcerative colitis. Journal of Crohn s and Colitis. 2(3). 263–268. 6 indexed citations
6.
Latella, Giovanni, et al.. (2008). Clinical course of Crohn’s disease first diagnosed at surgery for acute abdomen. Digestive and Liver Disease. 41(4). 269–276. 48 indexed citations
7.
Aratari, Annalisa, Angelo Viscido, Adriana Marcheggiano, et al.. (2006). Mucosal features and granulocyte–monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Digestive and Liver Disease. 38(6). 389–394. 19 indexed citations
8.
Caprilli, R., Emanuele Angelucci, Angelo Viscido, et al.. (2005). Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Digestive and Liver Disease. 37(6). 407–417. 26 indexed citations
9.
Viscido, Angelo, Annalisa Aratari, Francesca Maccioni, Alberto Signore, & R. Caprilli. (2005). Inflammatory bowel diseases: clinical update of practical guidelines. Nuclear Medicine Communications. 26(7). 649–655. 16 indexed citations
10.
Vernia, Piero, et al.. (2003). Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients. European Journal of Clinical Nutrition. 57(9). 1116–1119. 43 indexed citations
11.
Caprilli, R., Mario Cottone, Francesco Tonelli, et al.. (2003). Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial. Alimentary Pharmacology & Therapeutics. 17(4). 517–523. 68 indexed citations
12.
Vernia, Piero, Vito Annese, G. Bresci, et al.. (2003). Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial. European Journal of Clinical Investigation. 33(3). 244–248. 167 indexed citations
13.
Caprilli, R. & Danila Guagnozzi. (2003). CARD15 and Toll-like receptors: the link with Crohn’s disease. Digestive and Liver Disease. 35(11). 753–757. 4 indexed citations
14.
Latella, Giovanni, Piero Vernia, Angelo Viscido, et al.. (2002). GI distension in severe ulcerative colitis. The American Journal of Gastroenterology. 97(5). 1169–1175. 52 indexed citations
15.
Maccioni, Francesca, Angelo Viscido, Mario Marini, & R. Caprilli. (2002). MRI evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents. Abdominal Imaging. 27(4). 384–393. 46 indexed citations
16.
Caprilli, R. & Angelo Viscido. (1999). Evolving concepts on inflammatory bowel disease. Are we happy with the present nosology?. PubMed. 31(9). 893–7. 7 indexed citations
17.
Latella, Giovanni, Rosa Fonti, R. Caprilli, et al.. (1996). Characterization of the mucins produced by normal human colonocytes in primary culture. International Journal of Colorectal Disease. 11(2). 76–83. 9 indexed citations
18.
Vernia, Piero, Adriana Marcheggiano, R. Caprilli, et al.. (1995). Short‐chain fatty acid topical treatment in distal ulcerative colitis. Alimentary Pharmacology & Therapeutics. 9(3). 309–313. 188 indexed citations
19.
Campieri, Massimo, Giuseppe Brunetti, M. Miglioli, et al.. (1989). Topical treatment with 5-ASA supositories in distal ulcerative colitis. A randomized double blind placebo controlled study with Asacol suppositories. An Italian co-operative study group. 21. 15–16. 1 indexed citations
20.
Caprilli, R., et al.. (1976). Blood pH: a test for assessment of severity in proctocolitis.. Gut. 17(10). 763–769. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026